Riva y García Financial Group | Corporate Finance | Private equity | Private Banking |
2006 Business transactions
PDF
Date |
Client |
Transaction |
Value |
Logo |
05/2006 |
Astroc |
Public offering |
Confidential |
|
07/2006 |
Natraceutical |
Acquisition of 100% of the shares in Forté Pharma |
82 million EUROS |
|
07/2006 |
Mecanotubo |
Sale of 51% of capital |
Confidential |
|
10/2006 |
Natraceutical |
Capital increases |
61 million EUROS |
|
07/2006 |
Trader |
Sale of 100% of capital to Schibsted |
580 million EUROS |
|
ASTROC
The role of Riva y García:
Transaction amount: |
Public offering Flotation 121,190,000 shares RIVA Y GARCÍA acted as the Advisory Company and Placement Agent |
Natraceutical
The role of Riva y García:
Transaction amount: |
It has completed the acquisition of 100% of the Forté Pharma shares 82 million Euros RIVA Y GARCÍA acted as the Advisory Company, Lead Manager and Agent |
Mecanotubo Group
The role of Riva y García:
Transaction amount: |
Sale of 51% of capital RIVA Y GARCÍA acted as the Advisory Company |
Natraceutical
The role of Riva y García:
Transaction amount: |
Capital Increase 61,000 EUROS RIVA Y GARCÍA acted as the Advisory Company, Lead Manager and Agent |
Trader
The Norwegian group Schibsted has an 80% share in Spain of Multiprensa
The role of Riva y García:
Transaction amount: |
Sale of 100% of capital to Schibsted 580,000,000 Euros RIVA Y GARCÍA acted as the Advisory Company |